atezolizumab
Ligand Summary
A monoclonal antibody that targets programmed death-ligand 1 (CD274 ANTIGEN) and is used to treat urothelial carcinoma, the most common type of bladder cancer.
ChEMBL: CHEMBL3707227
DrugCentral: 5151
LyCHI: atezolizumab
Target Activities
1 Activities
Items per page:
1 – 1 of 1
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
---|---|---|---|---|---|---|
Kd | ANTIBODY BINDING | |||||